Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 1993-02, Vol.11 (2), p.336-344 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 344 |
|---|---|
| container_issue | 2 |
| container_start_page | 336 |
| container_title | Journal of clinical oncology |
| container_volume | 11 |
| creator | MURRAY, N COY, P SADURA, A FELD, R LEVITT, M WIERZBICKI, R AYOUB, J MAROUN, J. A WILSON, K. S PATER, J. L HODSON, I ARNOLD, A ZEE, B. C PAYNE, D KOSTASHUK, E. C EVANS, W. K DIXON, P |
| description | |
| doi_str_mv | 10.1200/JCO.1993.11.2.336 |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_4736440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4736440</sourcerecordid><originalsourceid>FETCH-LOGICAL-p182t-42ab43e4cfafa4e47889d0162aaa7fc1fec7d7589c75de1cc2059b0bada6fe603</originalsourceid><addsrcrecordid>eNotzUtLxDAYheEgCtbRH-AuC7epubVplzJ4GRmYjYK74WsuYyRpSxLB-fd20NWBs3hehG4ZrRmn9P51vatZ34uasZrXQrRnqGINV0SppjlHFVWCE9aJj0t0lfMXpUx2oqnQzybOUyowaosnh4uPfjxgNyVcPqcE2mvsUwLjofhpxH5cfov1FAc_WoPjZCD4csQlWSjRjuWkhEUp1pBc4GBxjhAC0TYEHL4XXJ9i6RpdOAjZ3vzvCr0_Pb6tX8h297xZP2zJzDpeiOQwSGGlduBAWqm6rjeUtRwAlNPMWa2Marpeq8ZYpjWnTT_QAQy0zrZUrNDdnztD1hBcWuo-7-fkI6TjXirRSknFLz68Yus</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer</title><source>American Society of Clinical Oncology Journals</source><source>Journals@Ovid Complete</source><creator>MURRAY, N ; COY, P ; SADURA, A ; FELD, R ; LEVITT, M ; WIERZBICKI, R ; AYOUB, J ; MAROUN, J. A ; WILSON, K. S ; PATER, J. L ; HODSON, I ; ARNOLD, A ; ZEE, B. C ; PAYNE, D ; KOSTASHUK, E. C ; EVANS, W. K ; DIXON, P</creator><creatorcontrib>MURRAY, N ; COY, P ; SADURA, A ; FELD, R ; LEVITT, M ; WIERZBICKI, R ; AYOUB, J ; MAROUN, J. A ; WILSON, K. S ; PATER, J. L ; HODSON, I ; ARNOLD, A ; ZEE, B. C ; PAYNE, D ; KOSTASHUK, E. C ; EVANS, W. K ; DIXON, P</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.1993.11.2.336</identifier><language>eng</language><publisher>Baltimore, MD: Lippincott Williams & Wilkins</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Combined treatments (chemotherapy of immunotherapy associated with an other treatment) ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Journal of clinical oncology, 1993-02, Vol.11 (2), p.336-344</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4736440$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>MURRAY, N</creatorcontrib><creatorcontrib>COY, P</creatorcontrib><creatorcontrib>SADURA, A</creatorcontrib><creatorcontrib>FELD, R</creatorcontrib><creatorcontrib>LEVITT, M</creatorcontrib><creatorcontrib>WIERZBICKI, R</creatorcontrib><creatorcontrib>AYOUB, J</creatorcontrib><creatorcontrib>MAROUN, J. A</creatorcontrib><creatorcontrib>WILSON, K. S</creatorcontrib><creatorcontrib>PATER, J. L</creatorcontrib><creatorcontrib>HODSON, I</creatorcontrib><creatorcontrib>ARNOLD, A</creatorcontrib><creatorcontrib>ZEE, B. C</creatorcontrib><creatorcontrib>PAYNE, D</creatorcontrib><creatorcontrib>KOSTASHUK, E. C</creatorcontrib><creatorcontrib>EVANS, W. K</creatorcontrib><creatorcontrib>DIXON, P</creatorcontrib><title>Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer</title><title>Journal of clinical oncology</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNotzUtLxDAYheEgCtbRH-AuC7epubVplzJ4GRmYjYK74WsuYyRpSxLB-fd20NWBs3hehG4ZrRmn9P51vatZ34uasZrXQrRnqGINV0SppjlHFVWCE9aJj0t0lfMXpUx2oqnQzybOUyowaosnh4uPfjxgNyVcPqcE2mvsUwLjofhpxH5cfov1FAc_WoPjZCD4csQlWSjRjuWkhEUp1pBc4GBxjhAC0TYEHL4XXJ9i6RpdOAjZ3vzvCr0_Pb6tX8h297xZP2zJzDpeiOQwSGGlduBAWqm6rjeUtRwAlNPMWa2Marpeq8ZYpjWnTT_QAQy0zrZUrNDdnztD1hBcWuo-7-fkI6TjXirRSknFLz68Yus</recordid><startdate>19930201</startdate><enddate>19930201</enddate><creator>MURRAY, N</creator><creator>COY, P</creator><creator>SADURA, A</creator><creator>FELD, R</creator><creator>LEVITT, M</creator><creator>WIERZBICKI, R</creator><creator>AYOUB, J</creator><creator>MAROUN, J. A</creator><creator>WILSON, K. S</creator><creator>PATER, J. L</creator><creator>HODSON, I</creator><creator>ARNOLD, A</creator><creator>ZEE, B. C</creator><creator>PAYNE, D</creator><creator>KOSTASHUK, E. C</creator><creator>EVANS, W. K</creator><creator>DIXON, P</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope></search><sort><creationdate>19930201</creationdate><title>Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer</title><author>MURRAY, N ; COY, P ; SADURA, A ; FELD, R ; LEVITT, M ; WIERZBICKI, R ; AYOUB, J ; MAROUN, J. A ; WILSON, K. S ; PATER, J. L ; HODSON, I ; ARNOLD, A ; ZEE, B. C ; PAYNE, D ; KOSTASHUK, E. C ; EVANS, W. K ; DIXON, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p182t-42ab43e4cfafa4e47889d0162aaa7fc1fec7d7589c75de1cc2059b0bada6fe603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MURRAY, N</creatorcontrib><creatorcontrib>COY, P</creatorcontrib><creatorcontrib>SADURA, A</creatorcontrib><creatorcontrib>FELD, R</creatorcontrib><creatorcontrib>LEVITT, M</creatorcontrib><creatorcontrib>WIERZBICKI, R</creatorcontrib><creatorcontrib>AYOUB, J</creatorcontrib><creatorcontrib>MAROUN, J. A</creatorcontrib><creatorcontrib>WILSON, K. S</creatorcontrib><creatorcontrib>PATER, J. L</creatorcontrib><creatorcontrib>HODSON, I</creatorcontrib><creatorcontrib>ARNOLD, A</creatorcontrib><creatorcontrib>ZEE, B. C</creatorcontrib><creatorcontrib>PAYNE, D</creatorcontrib><creatorcontrib>KOSTASHUK, E. C</creatorcontrib><creatorcontrib>EVANS, W. K</creatorcontrib><creatorcontrib>DIXON, P</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MURRAY, N</au><au>COY, P</au><au>SADURA, A</au><au>FELD, R</au><au>LEVITT, M</au><au>WIERZBICKI, R</au><au>AYOUB, J</au><au>MAROUN, J. A</au><au>WILSON, K. S</au><au>PATER, J. L</au><au>HODSON, I</au><au>ARNOLD, A</au><au>ZEE, B. C</au><au>PAYNE, D</au><au>KOSTASHUK, E. C</au><au>EVANS, W. K</au><au>DIXON, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer</atitle><jtitle>Journal of clinical oncology</jtitle><date>1993-02-01</date><risdate>1993</risdate><volume>11</volume><issue>2</issue><spage>336</spage><epage>344</epage><pages>336-344</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>Baltimore, MD</cop><pub>Lippincott Williams & Wilkins</pub><doi>10.1200/JCO.1993.11.2.336</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-183X |
| ispartof | Journal of clinical oncology, 1993-02, Vol.11 (2), p.336-344 |
| issn | 0732-183X 1527-7755 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_4736440 |
| source | American Society of Clinical Oncology Journals; Journals@Ovid Complete |
| subjects | Antineoplastic agents Biological and medical sciences Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Medical sciences Pharmacology. Drug treatments |
| title | Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A42%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Importance%20of%20timing%20for%20thoracic%20irradiation%20in%20the%20combined%20modality%20treatment%20of%20limited-stage%20small-cell%20lung%20cancer&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=MURRAY,%20N&rft.date=1993-02-01&rft.volume=11&rft.issue=2&rft.spage=336&rft.epage=344&rft.pages=336-344&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.1993.11.2.336&rft_dat=%3Cpascalfrancis%3E4736440%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |